Sodium chloride

Generic Name
Sodium chloride
Brand Names
Amphenol-40, As 3, Bi-peglyte, Bicart, Bss, Bss Ophthalmic Solution, Cardioplegic, Citrasate, Clinimix E 2.75/5, Colyte, Corvatrol, Dextrose and Electrolyte No. 75, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Eye Stream, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hemosate Ultra, Hespan, Hizentra, Hyperlyte, Intersol, Isolyte S, Isolyte S pH 7.4, Isoplate, Lactate 1-2-3, Lactated Ringers, Menopur, Moviprep, Muro 128, Naturalyte, Normosol-M, Normosol-R, Nulytely, Nxstage Pureflow, P-Care M, P-Care MG, P-care, P-care X, Peglyte, Phoxillum, Physiolyte, Physioneal 40, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Plenvu, Prismasol, Procalamine 3, Ringers, Sag-M, Sclerodex, Suflave, Tis-U-sol
Drug Type
Small Molecule
Chemical Formula
ClNa
CAS Number
7647-14-5
Unique Ingredient Identifier
451W47IQ8X
Background

Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential...

Indication

This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.

Associated Conditions
Allergic Rhinitis (AR), Corneal Edema, Dehydration, Dehydration Hypertonic, Fluid Loss, Hemodilution, Hypokalemia, Hyponatremia, Hypotonic Dehydration, Hypovolaemia, Increase in Intracranial Pressure (ICP), Increased Intra Ocular Pressure (IOP), Inflammation of the Nasal Mucosa, Isotonic Dehydration, Metabolic Acidosis, Nasal Congestion, Nasal irritation, Oliguria caused by Acute Renal Failure (ARF), Potassium deficiency, Sinusitis, Skin Irritation, Sodium Depletion, Dryness of the nose, Hypochloremic state, Mild Metabolic acidosis, Mild, moderate Metabolic Acidosis
Associated Therapies
Electrolyte replacement, Fluid replacement therapy, Heart-Lung-Machine, Oral rehydration therapy, Parenteral Nutrition, Parenteral rehydration therapy, Peritoneal dialysis therapy, Plasma Volume Replacement, Regional Citrate Anticoagulation (RCA), Renal Replacement Therapies, Urine alkalinization therapy, Wound irrigation therapy, Ear wax removal, Fluid and electrolyte maintenance therapy, Increased renal excretion of toxic substances, Maintenance source of fluid and electrolytes, Parenteral drug administration, Reducing brain mass

Use of Desmopressin Prior to Graft Kidney Biopsy in Patients with High Risk of Bleeding

First Posted Date
2024-10-02
Last Posted Date
2024-10-02
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Target Recruit Count
96
Registration Number
NCT06622187
Locations
🇧🇷

Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil

Role of IV Calcium to Prevent Diltiazem-related Hypotension

First Posted Date
2024-07-10
Last Posted Date
2024-07-11
Lead Sponsor
Haseki Training and Research Hospital
Target Recruit Count
217
Registration Number
NCT06494007
Locations
🇹🇷

Haseki Training and Research Hospital, Istanbul, Fatih, Turkey

Metreleptin in Anorexia Nervosa

Phase 2
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-03-12
Last Posted Date
2024-03-15
Lead Sponsor
Gabriella Milos
Target Recruit Count
50
Registration Number
NCT06305182
Locations
🇨🇭

Eating Disorder Unit, Clinic of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, Zurich, Switzerland

NAPO - Novel Approach for Oligospermia

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2024-03-08
Last Posted Date
2024-12-13
Lead Sponsor
Martin Blomberg Jensen
Target Recruit Count
42
Registration Number
NCT06300229
Locations
🇩🇰

Division of Translational Endocrinology, Department of Endocrinology and Internal Medicine, Copenhagen, Denmark

Impact of Postoperative Skin Disinfection With Chlorhexidine on Bacterial Colonization

Phase 4
Completed
Conditions
Interventions
First Posted Date
2023-11-02
Last Posted Date
2023-11-02
Lead Sponsor
Linkoeping University
Target Recruit Count
60
Registration Number
NCT06114459
Locations
🇸🇪

Ryhov Hospital, Jönköping, Småland, Sweden

Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis

Phase 2
Active, not recruiting
Conditions
Interventions
First Posted Date
2022-11-21
Last Posted Date
2024-04-10
Lead Sponsor
University of Bonn
Target Recruit Count
52
Registration Number
NCT05623592
Locations
🇩🇪

Medical Clinic and Polyclinic III Internal medicine Oncology, Hematology University Hospital Bonn, Rheumatology and Clinical Immunology, Bonn, Germany

Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function

First Posted Date
2022-10-17
Last Posted Date
2023-04-14
Lead Sponsor
University of Dundee
Target Recruit Count
20
Registration Number
NCT05582798
Locations
🇬🇧

NHS Tayside, Dundee, United Kingdom

Bicarbonate for In-Hospital Cardiac Arrest

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2022-10-03
Last Posted Date
2023-10-10
Lead Sponsor
Lars Wiuff Andersen
Target Recruit Count
778
Registration Number
NCT05564130
Locations
🇩🇰

Nykøbing Falster Hospital, Nykøbing Falster, Denmark

🇩🇰

Hospital of Southern Jutland - Aabenraa, Aabenraa, Denmark

🇩🇰

Copenhagen University Hospital - Herlev, Herlev, Denmark

and more 19 locations

Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery

First Posted Date
2022-04-25
Last Posted Date
2024-04-17
Lead Sponsor
Ilse van de Wijgert
Target Recruit Count
76
Registration Number
NCT05345249
Locations
🇳🇱

Sint Maartenskliniek, Ubbergen, Gelderland, Netherlands

© Copyright 2024. All Rights Reserved by MedPath